Michael Catlin serves as Executive at Kiromic Biopharma, Inc., where they oversee executive responsibilities. Since joining the company, Michael Catlin has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 18, 2024 involved receiving (via award) 18,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Mar 18, 2024 | KRBP | $0 | Award | 18,000 | $N/A | Discretionary |
Michael Catlin currently holds 25,500 shares of Kiromic Biopharma, Inc. (KRBP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Catlin has been a net neutral trader of KRBP stock. They have purchased $0 and sold $0 worth of shares.
Michael Catlin's most recent insider trade was on Mar 18, 2024, when they sold 18,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted